Harpoon Therapeutics Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Harpoon Therapeutics are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Harpoon Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Harpoon Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 51 M |
Harpoon |
Harpoon Therapeutics Relative Risk vs. Return Landscape
If you would invest (100.00) in Harpoon Therapeutics on December 23, 2024 and sell it today you would earn a total of 100.00 from holding Harpoon Therapeutics or generate -100.0% return on investment over 90 days. Harpoon Therapeutics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Harpoon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Harpoon Therapeutics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Harpoon Therapeutics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Harpoon Therapeutics, and traders can use it to determine the average amount a Harpoon Therapeutics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HARP |
Based on monthly moving average Harpoon Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Harpoon Therapeutics by adding Harpoon Therapeutics to a well-diversified portfolio.
Harpoon Therapeutics Fundamentals Growth
Harpoon Stock prices reflect investors' perceptions of the future prospects and financial health of Harpoon Therapeutics, and Harpoon Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Harpoon Stock performance.
| Return On Equity | -2.84 | |||
| Return On Asset | -0.36 | |||
| Profit Margin | (0.82) % | |||
| Operating Margin | (2.73) % | |||
| Current Valuation | 475.25 M | |||
| Shares Outstanding | 21.4 M | |||
| Price To Earning | (5.61) X | |||
| Price To Book | 108.42 X | |||
| Price To Sales | 13.19 X | |||
| Revenue | 37.34 M | |||
| EBITDA | (35.45 M) | |||
| Cash And Equivalents | 90.15 M | |||
| Cash Per Share | 2.72 X | |||
| Total Debt | 16.01 M | |||
| Debt To Equity | 0.43 % | |||
| Book Value Per Share | 1.10 X | |||
| Cash Flow From Operations | (69.38 M) | |||
| Earnings Per Share | (8.62) X | |||
| Total Asset | 73.73 M | |||
| Retained Earnings | (352.52 M) | |||
| Current Asset | 119.62 M | |||
| Current Liabilities | 18.4 M | |||
Things to note about Harpoon Therapeutics performance evaluation
Checking the ongoing alerts about Harpoon Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Harpoon Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Harpoon Therapeutics is not yet fully synchronised with the market data | |
| Harpoon Therapeutics has some characteristics of a very speculative penny stock | |
| Harpoon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 37.34 M. Net Loss for the year was (30.5 M) with loss before overhead, payroll, taxes, and interest of (49.48 M). | |
| Harpoon Therapeutics currently holds about 90.15 M in cash with (69.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. | |
| Over 83.0% of the company shares are owned by institutional investors |
- Analyzing Harpoon Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Harpoon Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Harpoon Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Harpoon Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Harpoon Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Harpoon Therapeutics' stock. These opinions can provide insight into Harpoon Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Harpoon Stock
If you are still planning to invest in Harpoon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Harpoon Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |